Skip to main content
Top
Published in: Sleep and Breathing 4/2020

Open Access 01-12-2020 | Sleep Apnea | Sleep Breathing Physiology and Disorders • Original Article

TLRs and RAGE are elevated in carotid plaques from patients with moderate-to-severe obstructive sleep apnea syndrome

Authors: Wioletta Olejarz, Alicja Głuszko, Agata Cyran, Katarzyna Bednarek-Rajewska, Robert Proczka, David F. Smith, Stacey L. Ishman, Ewa Migacz, Wojciech Kukwa

Published in: Sleep and Breathing | Issue 4/2020

Login to get access

Abstract

Background

There is growing evidence that obstructive sleep apnea (OSA) promotes vascular endothelial dysfunction and atherogenesis. Pathways that mediate this pathology may include Toll-like receptors (TLRs) and receptor for advanced glycation end products (RAGE) which play a significant role in proinflammatory processes. The aim of this study was to measure the expression of the above-mentioned receptors in relation to OSA severity in carotid plaques obtained during open endarterectomy.

Methods

This prospective study included patients with a sleep study prior to surgery and a plaque specimen obtained during standard open endarterectomy. Immunohistochemistry of TLR2, TLR4, TLR7, TLR9, RAGE, HMGB1, and NF-κB was performed on atherosclerotic plaques from carotid arteries of patients with and without OSA.

Results

There were 46 patients (22 women, mean age 73.2 ± 1.3 years): 14 control patients, 13 with mild, 11 with moderate, and 8 with severe OSA. The expression of all TLRs and RAGE increased proportionately with increasing OSA severity. The largest differences between patients with severe OSA and no OSA were found for TLR2 (2.88 ± 0.35 vs. 1.27 ± 0.47, p < 0.001), TLR4 (2.88 ± 0.35 vs. 1.64 ± 0.5, p < 0.001), TLR9 (2.38 ± 0.52 vs. 1.45 ± 0.52, p < 0.01), and RAGE (2.5 ± 0.53 vs. 1.82 ± 0.6, p < 0.05).

Conclusion

TLR2, TLR4, TLR9, and RAGE expression was significantly increased in carotid plaques of patients with moderate-to-severe OSA when compared with control patients with no OSA and those with mild OSA. TLR and RAGE-mediated pathways may play a significant role in OSA-dependent atherogenesis.
Literature
1.
go back to reference Eastwood PR, Malhotra A, Palmer LJ, Kezirian EJ, Horner RL, Ip MS, Thurnheer R, Antic NA, Hillman DR (2010) Obstructive sleep apnoea: from pathogenesis to treatment: current controversies and future directions. Respirology (Carlton, Vic) 15(4):587–595CrossRef Eastwood PR, Malhotra A, Palmer LJ, Kezirian EJ, Horner RL, Ip MS, Thurnheer R, Antic NA, Hillman DR (2010) Obstructive sleep apnoea: from pathogenesis to treatment: current controversies and future directions. Respirology (Carlton, Vic) 15(4):587–595CrossRef
2.
go back to reference Chen LD, Lin L, Lin XJ, Ou YW, Wu Z, Ye YM, Xu QZ, Huang YP, Cai ZM (2017) Effect of continuous positive airway pressure on carotid intima-media thickness in patients with obstructive sleep apnea: a meta-analysis. PLoS One 12(9):e0184293CrossRef Chen LD, Lin L, Lin XJ, Ou YW, Wu Z, Ye YM, Xu QZ, Huang YP, Cai ZM (2017) Effect of continuous positive airway pressure on carotid intima-media thickness in patients with obstructive sleep apnea: a meta-analysis. PLoS One 12(9):e0184293CrossRef
3.
go back to reference Catala R, Ferre R, Cabre A, Girona J, Porto M, Texido A, Masana L (2016) Long-term effects of continuous positive airway pressure treatment on subclinical atherosclerosis in obstructive sleep apnoea syndrome. Med Clin (Barc) 147(1):1–6CrossRef Catala R, Ferre R, Cabre A, Girona J, Porto M, Texido A, Masana L (2016) Long-term effects of continuous positive airway pressure treatment on subclinical atherosclerosis in obstructive sleep apnoea syndrome. Med Clin (Barc) 147(1):1–6CrossRef
4.
go back to reference Song D, Fang G, Mao SZ, Ye X, Liu G, Gong Y, Liu SF (2012) Chronic intermittent hypoxia induces atherosclerosis by NF-kappaB-dependent mechanisms. Biochim Biophys Acta 1822(11):1650–1659CrossRef Song D, Fang G, Mao SZ, Ye X, Liu G, Gong Y, Liu SF (2012) Chronic intermittent hypoxia induces atherosclerosis by NF-kappaB-dependent mechanisms. Biochim Biophys Acta 1822(11):1650–1659CrossRef
5.
go back to reference Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S, Sajid H, Naseem J, Loomba R (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9(10):1003–1012CrossRef Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S, Sajid H, Naseem J, Loomba R (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9(10):1003–1012CrossRef
6.
go back to reference Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, Diomedi M (2002) Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 33(7):1782–1785CrossRef Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, Diomedi M (2002) Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 33(7):1782–1785CrossRef
7.
go back to reference Nadeem R, Harvey M, Singh M, Khan AA, Albustani M, Baessler A, Madbouly EM, Sajid H, Khan M, Navid N (2013) Patients with obstructive sleep apnea display increased carotid intima media: a meta-analysis. Int J Vasc Med 2013:839582PubMedPubMedCentral Nadeem R, Harvey M, Singh M, Khan AA, Albustani M, Baessler A, Madbouly EM, Sajid H, Khan M, Navid N (2013) Patients with obstructive sleep apnea display increased carotid intima media: a meta-analysis. Int J Vasc Med 2013:839582PubMedPubMedCentral
8.
go back to reference Kylintireas I, Craig S, Nethononda R, Kohler M, Francis J, Choudhury R, Stradling J, Neubauer S (2012) Atherosclerosis and arterial stiffness in obstructive sleep apnea--a cardiovascular magnetic resonance study. Atherosclerosis 222(2):483–489CrossRef Kylintireas I, Craig S, Nethononda R, Kohler M, Francis J, Choudhury R, Stradling J, Neubauer S (2012) Atherosclerosis and arterial stiffness in obstructive sleep apnea--a cardiovascular magnetic resonance study. Atherosclerosis 222(2):483–489CrossRef
9.
go back to reference Kundel V, Trivieri MG, Karakatsanis NA, Robson PM, Mani V, Kizer JR, Kaplan R, Fayad Z, Shah N (2018) Assessment of atherosclerotic plaque activity in patients with sleep apnea using hybrid positron emission tomography/magnetic resonance imaging (PET/MRI): a feasibility study. Sleep Breath 22(4):1125–1135CrossRef Kundel V, Trivieri MG, Karakatsanis NA, Robson PM, Mani V, Kizer JR, Kaplan R, Fayad Z, Shah N (2018) Assessment of atherosclerotic plaque activity in patients with sleep apnea using hybrid positron emission tomography/magnetic resonance imaging (PET/MRI): a feasibility study. Sleep Breath 22(4):1125–1135CrossRef
10.
go back to reference Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):613–618CrossRef Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):613–618CrossRef
11.
go back to reference Kim J, Lee SK, Yoon DW, Shin C (2018) Obstructive sleep apnoea is associated with progression of arterial stiffness independent of obesity in participants without hypertension: a KoGES prospective cohort study. Sci Rep 8(1):8152CrossRef Kim J, Lee SK, Yoon DW, Shin C (2018) Obstructive sleep apnoea is associated with progression of arterial stiffness independent of obesity in participants without hypertension: a KoGES prospective cohort study. Sci Rep 8(1):8152CrossRef
12.
go back to reference Chen YC, Su MC, Liou CW, Liu SF, Chen CJ, Lin HC, Hsiao CC, Wang TY, Wang CC, Chin CH, Huang KT, Lin AS, Lin MC (2015) Co-upregulation of Toll-like receptors 2 and 6 on peripheral blood cells in patients with obstructive sleep apnea. Sleep Breath 19(3):873–882CrossRef Chen YC, Su MC, Liou CW, Liu SF, Chen CJ, Lin HC, Hsiao CC, Wang TY, Wang CC, Chin CH, Huang KT, Lin AS, Lin MC (2015) Co-upregulation of Toll-like receptors 2 and 6 on peripheral blood cells in patients with obstructive sleep apnea. Sleep Breath 19(3):873–882CrossRef
13.
go back to reference Roshan MH, Tambo A, Pace NP (2016) The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis. Int J Inflam pp 1532832 Roshan MH, Tambo A, Pace NP (2016) The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis. Int J Inflam pp 1532832
14.
go back to reference Olejarz W, Lacheta D, Gluszko A, Migacz E, Kukwa W, Szczepanski MJ, Tomaszewski P, Nowicka G (2018) RAGE and TLRs as key targets for antiatherosclerotic therapy. Biomed Res Int 2018:7675286CrossRef Olejarz W, Lacheta D, Gluszko A, Migacz E, Kukwa W, Szczepanski MJ, Tomaszewski P, Nowicka G (2018) RAGE and TLRs as key targets for antiatherosclerotic therapy. Biomed Res Int 2018:7675286CrossRef
15.
go back to reference Medeiros MC, Frasnelli SC, Bastos Ade S, Orrico SR, Rossa C Jr (2014) Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-KB. J Appl Oral Sci 22(3):185–193CrossRef Medeiros MC, Frasnelli SC, Bastos Ade S, Orrico SR, Rossa C Jr (2014) Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-KB. J Appl Oral Sci 22(3):185–193CrossRef
16.
go back to reference Kondo T, Kawai T, Akira S (2012) Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol 33(9):449–458CrossRef Kondo T, Kawai T, Akira S (2012) Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol 33(9):449–458CrossRef
17.
go back to reference Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G (2008) Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 197(1):95–104CrossRef Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G (2008) Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 197(1):95–104CrossRef
18.
go back to reference Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT, Koschinsky ML, Harkewicz R, Witztum JL, Tsimikas S, Golenbock D, Moore KJ, Tabas I (2010) Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12(5):467–482CrossRef Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT, Koschinsky ML, Harkewicz R, Witztum JL, Tsimikas S, Golenbock D, Moore KJ, Tabas I (2010) Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12(5):467–482CrossRef
19.
go back to reference Mullick AE, Soldau K, Kiosses WB, Bell TA 3rd, Tobias PS, Curtiss LK (2008) Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 205(2):373–383CrossRef Mullick AE, Soldau K, Kiosses WB, Bell TA 3rd, Tobias PS, Curtiss LK (2008) Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 205(2):373–383CrossRef
20.
go back to reference Higashimori M, Tatro JB, Moore KJ, Mendelsohn ME, Galper JB, Beasley D (2011) Role of Toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 31(1):50–57CrossRef Higashimori M, Tatro JB, Moore KJ, Mendelsohn ME, Galper JB, Beasley D (2011) Role of Toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 31(1):50–57CrossRef
21.
go back to reference Curtiss LK, Tobias PS (2009) Emerging role of Toll-like receptors in atherosclerosis. J Lipid Res 50(Suppl):S340–S345CrossRef Curtiss LK, Tobias PS (2009) Emerging role of Toll-like receptors in atherosclerosis. J Lipid Res 50(Suppl):S340–S345CrossRef
22.
go back to reference Katsargyris A, Theocharis SE, Tsiodras S, Giaginis K, Bastounis E, Klonaris C (2010) Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques. Expert Opin Ther Targets 14(1):1–10CrossRef Katsargyris A, Theocharis SE, Tsiodras S, Giaginis K, Bastounis E, Klonaris C (2010) Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques. Expert Opin Ther Targets 14(1):1–10CrossRef
23.
go back to reference Sorrentino R, Morello S, Chen S, Bonavita E, Pinto A (2010) The activation of liver X receptors inhibits toll-like receptor-9-induced foam cell formation. J Cell Physiol 223(1):158–167PubMed Sorrentino R, Morello S, Chen S, Bonavita E, Pinto A (2010) The activation of liver X receptors inhibits toll-like receptor-9-induced foam cell formation. J Cell Physiol 223(1):158–167PubMed
24.
go back to reference Mahajan N, Malik N, Bahl A, Dhawan V (2009) Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease. Atherosclerosis 207(2):597–602CrossRef Mahajan N, Malik N, Bahl A, Dhawan V (2009) Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease. Atherosclerosis 207(2):597–602CrossRef
25.
go back to reference Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA (2008) Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 57(9):2461–2469CrossRef Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA (2008) Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 57(9):2461–2469CrossRef
26.
go back to reference Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R (2004) Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 24(7):1266–1271CrossRef Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R (2004) Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 24(7):1266–1271CrossRef
27.
go back to reference Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D (2014) HMGB1 in health and disease. Mol Asp Med 40:1–116CrossRef Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D (2014) HMGB1 in health and disease. Mol Asp Med 40:1–116CrossRef
28.
go back to reference Yao D, Brownlee M (2010) Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 59(1):249–255CrossRef Yao D, Brownlee M (2010) Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 59(1):249–255CrossRef
29.
go back to reference Liu M, Yu Y, Jiang H, Zhang L, Zhang PP, Yu P, Jia JG, Chen RZ, Zou YZ, Ge JB (2013) Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis. Acta Pharmacol Sin 34(6):830–836CrossRef Liu M, Yu Y, Jiang H, Zhang L, Zhang PP, Yu P, Jia JG, Chen RZ, Zou YZ, Ge JB (2013) Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis. Acta Pharmacol Sin 34(6):830–836CrossRef
30.
go back to reference Akinnusi M, Jaoude P, Kufel T, El-Solh AA (2013) Toll-like receptor activity in patients with obstructive sleep apnea. Sleep Breath 17(3):1009–1016CrossRef Akinnusi M, Jaoude P, Kufel T, El-Solh AA (2013) Toll-like receptor activity in patients with obstructive sleep apnea. Sleep Breath 17(3):1009–1016CrossRef
31.
go back to reference Israel LP, Benharoch D, Gopas J, Goldbart AD (2013) A pro-inflammatory role for nuclear factor kappa B in childhood obstructive sleep apnea syndrome. Sleep 36(12):1947–1955CrossRef Israel LP, Benharoch D, Gopas J, Goldbart AD (2013) A pro-inflammatory role for nuclear factor kappa B in childhood obstructive sleep apnea syndrome. Sleep 36(12):1947–1955CrossRef
32.
go back to reference Floras JS (2018) Sleep apnea and cardiovascular disease: an enigmatic risk factor. Circ Res 122(12):1741–1764CrossRef Floras JS (2018) Sleep apnea and cardiovascular disease: an enigmatic risk factor. Circ Res 122(12):1741–1764CrossRef
33.
go back to reference Migacz E, Proczka R, Krzeski A, Kukwa W (2018) Obstructive sleep apnea in patients scheduled for endarterectomy - preliminary study. Otolaryngol Pol 72(4):17–20PubMed Migacz E, Proczka R, Krzeski A, Kukwa W (2018) Obstructive sleep apnea in patients scheduled for endarterectomy - preliminary study. Otolaryngol Pol 72(4):17–20PubMed
34.
go back to reference Lee SA, Amis TC, Byth K, Larcos G, Kairaitis K, Robinson TD, Wheatley JR (2008) Heavy snoring as a cause of carotid artery atherosclerosis. Sleep 31(9):1207–1213PubMedPubMedCentral Lee SA, Amis TC, Byth K, Larcos G, Kairaitis K, Robinson TD, Wheatley JR (2008) Heavy snoring as a cause of carotid artery atherosclerosis. Sleep 31(9):1207–1213PubMedPubMedCentral
Metadata
Title
TLRs and RAGE are elevated in carotid plaques from patients with moderate-to-severe obstructive sleep apnea syndrome
Authors
Wioletta Olejarz
Alicja Głuszko
Agata Cyran
Katarzyna Bednarek-Rajewska
Robert Proczka
David F. Smith
Stacey L. Ishman
Ewa Migacz
Wojciech Kukwa
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 4/2020
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-020-02029-w

Other articles of this Issue 4/2020

Sleep and Breathing 4/2020 Go to the issue

Sleep Breathing Physiology and Disorders • Letter to the Editors

Response to: Obstructive sleep apnea syndrome and obesity: screening ability

Sleep Breathing Physiology and Disorders • Review

Obstructive sleep apnea and cardiovascular disease, a story of confounders!

Sleep Breathing Physiology and Disorders • Original Article

Is cellular energy monitoring more responsive to hypoxia than pulse oximetry?

Sleep Breathing Physiology and Disorders • Letter to the Editors

Clinical evidence for a dynamic atrial fibrillation substrate in sleep apnea